Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-046862
Filing Date
2022-04-18
Accepted
2022-04-18 16:13:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm223565d3_defa14a.htm DEFA14A 14198
2 GRAPHIC tm223565d3_defa14a-img001.jpg GRAPHIC 312713
3 GRAPHIC tm223565d3_defa14a-img002.jpg GRAPHIC 247222
  Complete submission text file 0001104659-22-046862.txt   786720
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39202 | Film No.: 22832293
SIC: 2834 Pharmaceutical Preparations